IRCT20150721023282N3
Completed
Phase 3
Evaluation of The Effect of N-acetylcysteine in The Prevention of Vancomycin-Induced Nephrotoxicity
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Esfahan University of Medical Sciences
- Enrollment
- 80
- Status
- Completed
- Last Updated
- 7 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Treatment with Vancomycin for at Least 5 Days
- •Creatinine Clearance \> 60 ml/min (Based on MDRD Formula)
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Phase 2
protective effect of N-acetylcysteine on taxane neuropathyPeripheral neuropathy.Polyneuropathy in diseases classified elsewhereIRCT20090613002027N20Mazandaran University of Medical Sciences60
Recruiting
Phase 4
Evaluation of the effect of N-acetyl cysteine on the prognosis of hospitalized children with covid 19 : a pilot-randomized-double blinded-placebo-controlled clinical trialIRCT20220516054879N1Rasht University of Medical Sciences40
Completed
Phase 3
The effect of N-acetylcysteine ??(NAC) on renal failure in Coronary surgeryPatients undergoing open heart surgery.IRCT20200823048491N1Esfahan University of Medical Sciences100
Completed
Phase 3
Effects of N-acetylcysteine administration in treatment of women with gestational diabetes mellitusGestational diabetes mellitus.Unspecified diabetes mellitus in pregnancy, childbirth and the puerperiumO24.9IRCT20170513033941N71Kashan University of Medical Sciences76
Completed
Phase 3
Study of the Effect of N-acetylcysteine on Urinary Tract Infection in Children.IRCT2013112015465N1Shahid Beheshti Medical University, Faculty of Pharmacy64